Research Studies

ECLIPSE Study. Enrollment has closed.

This is a mulitcenter, phase 3 study using a new drug named Fovista (antiPDGF). The objectives of this study are to evaluate the safety and efficacy of intravitreal administration of Fovista® administered in combination with Lucentis compared to Lucentis monotherapy in subjects with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD).

Current Progress

We are working on.. stuff.

Learn More!

PALADIN Study- enrollment is ongoing.

The specific objectives include the study of intraocular pressure (IOP) related data in patients who received ILUVIEN for the treatment of diabetic macular edema and how it relates to the patient's experiences following prior treatment with a course of corticosteroid which did not result in a clinically significant IOP elevation.

Current Progress

We are working on.. stuff.

Learn More!

HAWK Study -Enrollment is ongoing.

The purpose of this study is to compare RTH258 ophthalmic solution for intravitreal (IVT) injection at two dosage levels to aflibercept solution for IVT injection (2 mg) in subjects with untreated active choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) in the study eye.

Current Progress

We are working on.. stuff.

Learn More!

Del Mar phase 2B DME Study- enrollment is ongoing.

A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema

Current Progress

We are working on.. stuff.

Learn More!

CEDAR Study- Enrollment is ongoing

This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration.

Current Progress

We are working on.. stuff.

Learn More!

PVD Study -Enrollment is ongoing.

A Phase 2, Randomized, Double-masked, Placebo-controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy of Luminate in Inducing PVD in Subjects with Non-Proliferative Diabetic Retinopathy.

Current Progress

We are working on.. stuff.

Learn More!

Book Your Appointment Today

We have two convenient locations in Shirley and Commack of New York. Please feel free to call into our offices to learn more.

Contact Us